Viewing Study NCT00797992


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-02-06 @ 4:48 AM
Study NCT ID: NCT00797992
Status: COMPLETED
Last Update Posted: 2008-11-25
First Post: 2008-11-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
Sponsor: Instituto de Olhos de Goiania
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myopic Choroidal Neovascularization View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bevacizumab View
None Myopia View
None Complications View
None Neovascularization View
None OCT View